| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.8 | 1.5 | 1 | 2.8 | 16.1 | 87.3 | 51.9 | 1 | - | - | 162.3 |
| 0.4 | 1 | 0.5 | - | 1.8 | 25.9 | 20.5 | - | - | - | 50.1 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 2,098 | 99.5% | -1.65 | 669 | 99.1% |
| Optic-unspecified(L) | 11 | 0.5% | -0.87 | 6 | 0.9% |
| upstream partner | # | NT | conns Cm18 | % In | CV |
|---|---|---|---|---|---|
| Dm-DRA1 (L) | 22 | Glu | 40.2 | 27.9% | 0.4 |
| MeTu2a (L) | 33 | ACh | 32.2 | 22.4% | 0.4 |
| Cm21 (L) | 9 | GABA | 17.2 | 11.9% | 0.7 |
| MeTu3a (L) | 20 | ACh | 13.9 | 9.7% | 0.4 |
| Cm28 (L) | 6 | Glu | 4.1 | 2.9% | 0.7 |
| Cm4 (L) | 23 | Glu | 4.1 | 2.8% | 0.6 |
| R7d | 14 | HA | 3.8 | 2.6% | 0.7 |
| MeVC27 (R) | 3 | unc | 3 | 2.1% | 0.2 |
| Mi15 (L) | 36 | ACh | 3 | 2.1% | 0.4 |
| MeTu3c (L) | 13 | ACh | 1.9 | 1.3% | 0.4 |
| MeVP31 (L) | 1 | ACh | 1.7 | 1.2% | 0.0 |
| MeVP15 (L) | 11 | ACh | 1.5 | 1.0% | 0.5 |
| Dm11 (L) | 8 | Glu | 1.4 | 1.0% | 0.7 |
| MeTu3b (L) | 11 | ACh | 1.4 | 1.0% | 0.7 |
| Cm-DRA (L) | 4 | ACh | 1.4 | 0.9% | 0.6 |
| MeTu1 (L) | 9 | ACh | 1.1 | 0.8% | 0.6 |
| MeTu2b (L) | 7 | ACh | 0.9 | 0.6% | 0.4 |
| Cm22 (L) | 6 | GABA | 0.9 | 0.6% | 0.4 |
| Cm34 (L) | 1 | Glu | 0.8 | 0.5% | 0.0 |
| Dm8b (L) | 3 | Glu | 0.7 | 0.5% | 0.8 |
| Cm20 (L) | 7 | GABA | 0.6 | 0.4% | 0.4 |
| Cm14 (L) | 8 | GABA | 0.6 | 0.4% | 0.3 |
| Dm2 (L) | 5 | ACh | 0.5 | 0.3% | 0.6 |
| Dm-DRA2 (L) | 3 | Glu | 0.4 | 0.3% | 0.4 |
| Cm11a (L) | 2 | ACh | 0.4 | 0.2% | 0.6 |
| MeVPMe10 (R) | 1 | Glu | 0.4 | 0.2% | 0.0 |
| MeVC2 (R) | 1 | ACh | 0.3 | 0.2% | 0.0 |
| Cm17 (L) | 4 | GABA | 0.3 | 0.2% | 0.0 |
| MeLo3b (L) | 2 | ACh | 0.2 | 0.1% | 0.3 |
| Tm5b (L) | 2 | ACh | 0.2 | 0.1% | 0.3 |
| Cm11d (L) | 3 | ACh | 0.2 | 0.1% | 0.0 |
| Cm31a (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| Cm19 (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| Cm1 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Cm8 (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| Cm11c (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Mi9 (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| Tm39 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| MeVP55 (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| MeVC20 (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| MeVC4a (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| MeVP6 (L) | 2 | Glu | 0.1 | 0.1% | 0.0 |
| Cm25 (L) | 2 | Glu | 0.1 | 0.1% | 0.0 |
| MeVP14 (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| Mi10 (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| Cm18 (L) | 2 | Glu | 0.1 | 0.1% | 0.0 |
| MeLo5 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm6 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm10 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| aMe5 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe3 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeLo6 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm7 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeTu4a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm5 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Cm27 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm4 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm37 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Mi13 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Mi1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm11b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm8a (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeTu4c (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP12 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm5c (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| aMe9 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm33 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Tm20 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm3 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 0.1 | 0.0% | 0.0 |
| OA-AL2i3 (L) | 1 | OA | 0.1 | 0.0% | 0.0 |
| MeVCMe1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY10 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY20 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm24 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm6 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm16 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Cm18 | % Out | CV |
|---|---|---|---|---|---|
| MeVP15 (L) | 13 | ACh | 26.4 | 20.5% | 0.3 |
| MeTu3b (L) | 20 | ACh | 17.8 | 13.8% | 0.8 |
| Cm35 (L) | 1 | GABA | 17 | 13.2% | 0.0 |
| Cm20 (L) | 11 | GABA | 11.1 | 8.7% | 1.0 |
| Cm21 (L) | 10 | GABA | 8.1 | 6.3% | 0.5 |
| MeTu3a (L) | 18 | ACh | 6.7 | 5.2% | 0.9 |
| Cm10 (L) | 30 | GABA | 5.9 | 4.6% | 0.7 |
| MeVP31 (L) | 1 | ACh | 4.6 | 3.6% | 0.0 |
| Tm5c (L) | 29 | Glu | 4.3 | 3.3% | 0.6 |
| Cm28 (L) | 5 | Glu | 2.7 | 2.1% | 0.5 |
| Mi14 (L) | 11 | Glu | 2.3 | 1.8% | 0.6 |
| Cm22 (L) | 6 | GABA | 2.1 | 1.6% | 0.3 |
| MeTu2b (L) | 7 | ACh | 1.5 | 1.2% | 0.5 |
| MeVPMe11 (L) | 1 | Glu | 1.1 | 0.8% | 0.0 |
| MeTu3c (L) | 5 | ACh | 1 | 0.8% | 1.3 |
| Cm6 (L) | 6 | GABA | 0.9 | 0.7% | 0.4 |
| Cm9 (L) | 5 | Glu | 0.9 | 0.7% | 0.4 |
| aMe9 (L) | 2 | ACh | 0.8 | 0.6% | 0.5 |
| Cm31b (L) | 1 | GABA | 0.7 | 0.6% | 0.0 |
| aMe5 (L) | 3 | ACh | 0.7 | 0.6% | 0.1 |
| Cm4 (L) | 7 | Glu | 0.7 | 0.6% | 0.3 |
| Dm20 (L) | 4 | Glu | 0.6 | 0.5% | 0.2 |
| MeTu2a (L) | 6 | ACh | 0.6 | 0.5% | 0.3 |
| MeVPMe3 (L) | 1 | Glu | 0.6 | 0.4% | 0.0 |
| Dm-DRA2 (L) | 2 | Glu | 0.5 | 0.4% | 0.7 |
| MeTu1 (L) | 5 | ACh | 0.5 | 0.4% | 0.3 |
| Dm18 (L) | 5 | GABA | 0.5 | 0.4% | 0.3 |
| Cm14 (L) | 5 | GABA | 0.5 | 0.4% | 0.6 |
| aMe26 (L) | 2 | ACh | 0.4 | 0.3% | 0.6 |
| Cm11a (L) | 2 | ACh | 0.3 | 0.2% | 0.5 |
| Mi2 (L) | 2 | Glu | 0.3 | 0.2% | 0.5 |
| TmY10 (L) | 3 | ACh | 0.3 | 0.2% | 0.4 |
| Tm4 (L) | 3 | ACh | 0.3 | 0.2% | 0.4 |
| MeVPMe10 (L) | 1 | Glu | 0.3 | 0.2% | 0.0 |
| Cm31a (L) | 2 | GABA | 0.3 | 0.2% | 0.0 |
| Dm-DRA1 (L) | 4 | Glu | 0.3 | 0.2% | 0.0 |
| MeVP12 (L) | 2 | ACh | 0.3 | 0.2% | 0.5 |
| Cm1 (L) | 1 | ACh | 0.2 | 0.2% | 0.0 |
| Cm12 (L) | 1 | GABA | 0.2 | 0.2% | 0.0 |
| TmY15 (L) | 1 | GABA | 0.2 | 0.2% | 0.0 |
| MeVP63 (L) | 1 | GABA | 0.2 | 0.2% | 0.0 |
| Cm5 (L) | 2 | GABA | 0.2 | 0.2% | 0.3 |
| Cm8 (L) | 3 | GABA | 0.2 | 0.2% | 0.0 |
| Dm2 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| TmY19b (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| Mi9 (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| MeVP45 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| ME_LO_unclear (L) | 1 | unc | 0.1 | 0.1% | 0.0 |
| aMe17e (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| MeLo3b (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| Cm18 (L) | 2 | Glu | 0.1 | 0.1% | 0.0 |
| Cm25 (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| Mi15 (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| Mi16 (L) | 2 | GABA | 0.1 | 0.1% | 0.0 |
| Cm3 (L) | 2 | GABA | 0.1 | 0.1% | 0.0 |
| Tm37 (L) | 2 | Glu | 0.1 | 0.1% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| T2 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Cm11c (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| MeVC27 (R) | 1 | unc | 0.1 | 0.1% | 0.0 |
| Tm20 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Mi10 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| MeVPMe5 (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| MeVPMe4 (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| Tm5a (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| TmY9b (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| R7d | 1 | HA | 0.1 | 0.1% | 0.0 |
| MeLo5 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Dm16 (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| Lawf1 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| aMe4 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| TmY18 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Tm12 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| MeTu4c (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Pm4 (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| Tm6 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Mi1 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |